Cannara Biotech (LOVE.TO) appointed Nicholas Fozard, as its Chief Financial Officer, it said in a statement on Tuesday.
Fozard's appointment as CFO will take effect upon his receipt of the Health Canada security clearance needed of all of its officers and directors, it said. Most recently, Fozard served as the Vice President, Finance at Organigram Global.
Sosiak, who served as the company's CFO from 2020 until his appointment as Chief Operating Officer on April 23, and who has continued to serve as interim CFO during the search, will now transition fully into his role as COO.
Shares of the company closed unchanged at C$1.99 on Monday on the Toronto Stock Exchange.